Uroguanylin: Physiological role as a natriuretic hormone

Journal of the American Society of Nephrology

Volumn 16, Issue 2, 2005, Pages 291-292

  Forte, Leonard Ralph ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CYCLIC GMP; ESCHERICHIA COLI ENTEROTOXIN; GUANYLATE CYCLASE; GUANYLIN; MESSENGER RNA; UROGUANYLIN; BIOLOGICAL MARKER; NATRIURETIC FACTOR; PEPTIDE;

CELL FUNCTION; CONGESTIVE HEART FAILURE; EDITORIAL; GASTROINTESTINAL TRACT; INTESTINE EPITHELIUM; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; KNOCKOUT MOUSE; NEPHROSIS; NEPHROTIC SYNDROME; NONHUMAN; OPOSSUM; PRIORITY JOURNAL; SODIUM RETENTION; URINARY EXCRETION; ANIMAL; COMPARATIVE STUDY; HOSPITALIZATION; HUMAN; METABOLISM; NOTE; PATHOPHYSIOLOGY; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; NATRIURETIC AGENTS; NATRIURETIC PEPTIDES; NEPHROTIC SYNDROME; PEPTIDES; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 20544467201     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004121061     Document Type: Editorial

References (15)

1. Kinoshita H, Fujimoto S, Fukae H, Yokota N, Hisanaga S, Nakazato M, Eto T: Plasma and urine levels of uroguanylin, a new natriuretic peptide, in nephrotic syndrome. Nephron 8: 160-164, 1999
2. Forte LR, London RM, Freeman RH, Krause WJ: Guanylin peptides: Renal actions mediated by cyclic GMP. Am J Physiol Renal Physiol 278: F180-F191, 2000
3. Forte LR, London RM, Krause WJ, Freeman RH: Mechanisms of guanylin action via cyclic GMP in the kidney. Annu Rev Physiol 62: 673-695, 2000
4. Forte LR, Krause WJ, Freeman RH. Receptors and cGMP signaling mechanism for E. coli enterotoxin in opossum kidney. Am J Physiol 255: F1040-F1046, 1988
5. Field M: Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest 111: 931-943, 2003
6. Currie MG, Fok KF, Kato J, Moore RJ, Hamra FK, Duffin KL, Smith CE: Guanylin: An endogenous activator of intestinal guanylate cyclase. Proc Natl Acad Sci U S A 89: 947-951, 1992
7. Hamra FK, Forte LR, Eber SL, Pidhorodeckyj NV, Krause WJ, Freeman RH, Chin DT, Tompkins JA, Fok KF, Smith CE, Duffin KL, Siegel NR, Currie MG: Uroguanylin: Structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase. Proc Natl Acad Sci U S A 90: 10464-10468, 1993
8. Schulz S, Lopez MJ, Kuhn M, Garbers DL: Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice. J Clin Invest 100: 1590-1595, 1997
9. Steinbrecher KA, Wowk SA, Rudolph JA, Witte DP, Cohen MB: Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonie epithelial proliferation. Am J Pathol 161: 2169-2178, 2002
10. Lorenz JN, Nieman M, Sabo J, Sanford LP, Hawkins JA, Elitsur N, Gawenis LR, Clarke LL, Cohen MB: Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enterai NaCl load. J Clin Invest 112: 1244-1254, 2003
11. Lima AAM, Monteiro HSA, Fonteles MC: The effects of Escherichia coli heat-stable enterotoxin in renal sodium tubular transport. Pharmacol Toxicol 70:163-167, 1992
12. Fonteles MC, Greenberg RN, Monteiro HS, Currie MG, Forte LR: Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidney. Am J Physiol 275: F191-F197, 1998
13. Carrithers SL, Hill MJ, Johnson BJ, O'Hara SM, Jackson BA, Ott CE, Lorenz J, Mann EA, Giannella RA, Forte LR, Greenberg RN: Renal effects of uroguanylin and guanylin in vivo. Braz J Med Biol Res 32: 1337-1344, 1999
14. Forte LR, Fan X, Hamra FK: Salt and water homeostasis: Uroguanylin is a circulating peptide hormone with natriuretic activity. Am J Kidney Diseases 28: 296-304, 1996
15. Carrithers SL, Eber SL, Forte LR, Greenberg RN: Increased urinary excretion of uroguanylin in patients with congestive heart failure. Am J Physiol (Lond) 278: H538-H547, 2000